1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Infertility Services Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Assisted Reproductive Technology (ART)
  • 1.2.3 Infertility drug services
  • 1.2.4 Artificial Insemination
  • 1.2.5 Fertility Surgeries
• 1.3 Market by Application
  • 1.3.1 Global Infertility Services Market Share by Application: 2020 VS 2026
  • 1.3.2 Male
  • 1.3.3 Female
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Infertility Services Market Perspective (2015-2026)
• 2.2 Global Infertility Services Growth Trends by Regions
  • 2.2.1 Infertility Services Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infertility Services Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infertility Services Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Infertility Services Players by Market Size
  • 3.1.1 Global Top Infertility Services Players by Revenue (2015-2020)
  • 3.1.2 Global Infertility Services Revenue Market Share by Players (2015-2020)
• 3.2 Global Infertility Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Infertility Services Revenue
• 3.4 Global Infertility Services Market Concentration Ratio
  • 3.4.1 Global Infertility Services Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Infertility Services Revenue in 2019
• 3.5 Key Players Infertility Services Area Served
• 3.6 Key Players Infertility Services Product Solution and Service
• 3.7 Date of Enter into Infertility Services Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Infertility Services Breakdown Data by Type (2015-2026)

• 4.1 Global Infertility Services Historic Market Size by Type (2015-2020)
• 4.2 Global Infertility Services Forecasted Market Size by Type (2021-2026)

5 Infertility Services Breakdown Data by Application (2015-2026)

• 5.1 Global Infertility Services Historic Market Size by Application (2015-2020)
• 5.2 Global Infertility Services Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infertility Services Market Size (2015-2026)
• 6.2 North America Infertility Services Market Size by Type (2015-2020)
• 6.3 North America Infertility Services Market Size by Application (2015-2020)
• 6.4 North America Infertility Services Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Infertility Services Market Size (2015-2026)
• 7.2 Europe Infertility Services Market Size by Type (2015-2020)
• 7.3 Europe Infertility Services Market Size by Application (2015-2020)
• 7.4 Europe Infertility Services Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Infertility Services Market Size (2015-2026)
• 8.2 China Infertility Services Market Size by Type (2015-2020)
• 8.3 China Infertility Services Market Size by Application (2015-2020)
• 8.4 China Infertility Services Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Infertility Services Market Size (2015-2026)
• 9.2 Japan Infertility Services Market Size by Type (2015-2020)
• 9.3 Japan Infertility Services Market Size by Application (2015-2020)
• 9.4 Japan Infertility Services Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Infertility Services Market Size (2015-2026)
• 10.2 Southeast Asia Infertility Services Market Size by Type (2015-2020)
• 10.3 Southeast Asia Infertility Services Market Size by Application (2015-2020)
• 10.4 Southeast Asia Infertility Services Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 CARE facility
  • 11.1.1 CARE facility Company Details
  • 11.1.2 CARE facility Business Overview
  • 11.1.3 CARE facility Infertility Services Introduction
  • 11.1.4 CARE facility Revenue in Infertility Services Business (2015-2020))
  • 11.1.5 CARE facility Recent Development
• 11.2 CooperSurgical
  • 11.2.1 CooperSurgical Company Details
  • 11.2.2 CooperSurgical Business Overview
  • 11.2.3 CooperSurgical Infertility Services Introduction
  • 11.2.4 CooperSurgical Revenue in Infertility Services Business (2015-2020)
  • 11.2.5 CooperSurgical Recent Development
• 11.3 Ferring Pharmaceuticals
  • 11.3.1 Ferring Pharmaceuticals Company Details
  • 11.3.2 Ferring Pharmaceuticals Business Overview
  • 11.3.3 Ferring Pharmaceuticals Infertility Services Introduction
  • 11.3.4 Ferring Pharmaceuticals Revenue in Infertility Services Business (2015-2020)
  • 11.3.5 Ferring Pharmaceuticals Recent Development
• 11.4 Monash IVF
  • 11.4.1 Monash IVF Company Details
  • 11.4.2 Monash IVF Business Overview
  • 11.4.3 Monash IVF Infertility Services Introduction
  • 11.4.4 Monash IVF Revenue in Infertility Services Business (2015-2020)
  • 11.4.5 Monash IVF Recent Development
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Merck Business Overview
  • 11.5.3 Merck Infertility Services Introduction
  • 11.5.4 Merck Revenue in Infertility Services Business (2015-2020)
  • 11.5.5 Merck Recent Development
• 11.6 Vitrolife
  • 11.6.1 Vitrolife Company Details
  • 11.6.2 Vitrolife Business Overview
  • 11.6.3 Vitrolife Infertility Services Introduction
  • 11.6.4 Vitrolife Revenue in Infertility Services Business (2015-2020)
  • 11.6.5 Vitrolife Recent Development
• 11.7 AbbVie
  • 11.7.1 AbbVie Company Details
  • 11.7.2 AbbVie Business Overview
  • 11.7.3 AbbVie Infertility Services Introduction
  • 11.7.4 AbbVie Revenue in Infertility Services Business (2015-2020)
  • 11.7.5 AbbVie Recent Development
• 11.8 Apricus Biosciences
  • 11.8.1 Apricus Biosciences Company Details
  • 11.8.2 Apricus Biosciences Business Overview
  • 11.8.3 Apricus Biosciences Infertility Services Introduction
  • 11.8.4 Apricus Biosciences Revenue in Infertility Services Business (2015-2020)
  • 11.8.5 Apricus Biosciences Recent Development
• 11.9 AstraZeneca
  • 11.9.1 AstraZeneca Company Details
  • 11.9.2 AstraZeneca Business Overview
  • 11.9.3 AstraZeneca Infertility Services Introduction
  • 11.9.4 AstraZeneca Revenue in Infertility Services Business (2015-2020)
  • 11.9.5 AstraZeneca Recent Development
• 11.10 Auxogyn
  • 11.10.1 Auxogyn Company Details
  • 11.10.2 Auxogyn Business Overview
  • 11.10.3 Auxogyn Infertility Services Introduction
  • 11.10.4 Auxogyn Revenue in Infertility Services Business (2015-2020)
  • 11.10.5 Auxogyn Recent Development
• 11.11 Eli Lilly
  • 10.11.1 Eli Lilly Company Details
  • 10.11.2 Eli Lilly Business Overview
  • 10.11.3 Eli Lilly Infertility Services Introduction
  • 10.11.4 Eli Lilly Revenue in Infertility Services Business (2015-2020)
  • 10.11.5 Eli Lilly Recent Development
• 11.12 EMD Serono
  • 10.12.1 EMD Serono Company Details
  • 10.12.2 EMD Serono Business Overview
  • 10.12.3 EMD Serono Infertility Services Introduction
  • 10.12.4 EMD Serono Revenue in Infertility Services Business (2015-2020)
  • 10.12.5 EMD Serono Recent Development
• 11.13 IKS International
  • 10.13.1 IKS International Company Details
  • 10.13.2 IKS International Business Overview
  • 10.13.3 IKS International Infertility Services Introduction
  • 10.13.4 IKS International Revenue in Infertility Services Business (2015-2020)
  • 10.13.5 IKS International Recent Development
• 11.14 InVitro Care
  • 10.14.1 InVitro Care Company Details
  • 10.14.2 InVitro Care Business Overview
  • 10.14.3 InVitro Care Infertility Services Introduction
  • 10.14.4 InVitro Care Revenue in Infertility Services Business (2015-2020)
  • 10.14.5 InVitro Care Recent Development
• 11.15 INVO Bioscience
  • 10.15.1 INVO Bioscience Company Details
  • 10.15.2 INVO Bioscience Business Overview
  • 10.15.3 INVO Bioscience Infertility Services Introduction
  • 10.15.4 INVO Bioscience Revenue in Infertility Services Business (2015-2020)
  • 10.15.5 INVO Bioscience Recent Development
• 11.16 Irvine Scientific
  • 10.16.1 Irvine Scientific Company Details
  • 10.16.2 Irvine Scientific Business Overview
  • 10.16.3 Irvine Scientific Infertility Services Introduction
  • 10.16.4 Irvine Scientific Revenue in Infertility Services Business (2015-2020)
  • 10.16.5 Irvine Scientific Recent Development
• 11.17 LifeGlobal
  • 10.17.1 LifeGlobal Company Details
  • 10.17.2 LifeGlobal Business Overview
  • 10.17.3 LifeGlobal Infertility Services Introduction
  • 10.17.4 LifeGlobal Revenue in Infertility Services Business (2015-2020)
  • 10.17.5 LifeGlobal Recent Development
• 11.18 MedITEX
  • 10.18.1 MedITEX Company Details
  • 10.18.2 MedITEX Business Overview
  • 10.18.3 MedITEX Infertility Services Introduction
  • 10.18.4 MedITEX Revenue in Infertility Services Business (2015-2020)
  • 10.18.5 MedITEX Recent Development
• 11.19 NMC Health
  • 10.19.1 NMC Health Company Details
  • 10.19.2 NMC Health Business Overview
  • 10.19.3 NMC Health Infertility Services Introduction
  • 10.19.4 NMC Health Revenue in Infertility Services Business (2015-2020)
  • 10.19.5 NMC Health Recent Development
• 11.20 OB GYN Associates
  • 10.20.1 OB GYN Associates Company Details
  • 10.20.2 OB GYN Associates Business Overview
  • 10.20.3 OB GYN Associates Infertility Services Introduction
  • 10.20.4 OB GYN Associates Revenue in Infertility Services Business (2015-2020)
  • 10.20.5 OB GYN Associates Recent Development
• 11.21 OvaScience
  • 10.21.1 OvaScience Company Details
  • 10.21.2 OvaScience Business Overview
  • 10.21.3 OvaScience Infertility Services Introduction
  • 10.21.4 OvaScience Revenue in Infertility Services Business (2015-2020)
  • 10.21.5 OvaScience Recent Development
• 11.22 Pantec Biosolutions
  • 10.22.1 Pantec Biosolutions Company Details
  • 10.22.2 Pantec Biosolutions Business Overview
  • 10.22.3 Pantec Biosolutions Infertility Services Introduction
  • 10.22.4 Pantec Biosolutions Revenue in Infertility Services Business (2015-2020)
  • 10.22.5 Pantec Biosolutions Recent Development
• 11.23 Reproductive Medicine Associates of New Jersey
  • 10.23.1 Reproductive Medicine Associates of New Jersey Company Details
  • 10.23.2 Reproductive Medicine Associates of New Jersey Business Overview
  • 10.23.3 Reproductive Medicine Associates of New Jersey Infertility Services Introduction
  • 10.23.4 Reproductive Medicine Associates of New Jersey Revenue in Infertility Services Business (2015-2020)
  • 10.23.5 Reproductive Medicine Associates of New Jersey Recent Development
• 11.24 The Sims Clinic
  • 10.24.1 The Sims Clinic Company Details
  • 10.24.2 The Sims Clinic Business Overview
  • 10.24.3 The Sims Clinic Infertility Services Introduction
  • 10.24.4 The Sims Clinic Revenue in Infertility Services Business (2015-2020)
  • 10.24.5 The Sims Clinic Recent Development
• 11.25 TriHealth
  • 10.25.1 TriHealth Company Details
  • 10.25.2 TriHealth Business Overview
  • 10.25.3 TriHealth Infertility Services Introduction
  • 10.25.4 TriHealth Revenue in Infertility Services Business (2015-2020)
  • 10.25.5 TriHealth Recent Development
• 11.26 Virtus Health
  • 10.26.1 Virtus Health Company Details
  • 10.26.2 Virtus Health Business Overview
  • 10.26.3 Virtus Health Infertility Services Introduction
  • 10.26.4 Virtus Health Revenue in Infertility Services Business (2015-2020)
  • 10.26.5 Virtus Health Recent Development
• 11.27 Xytex Cryo International
  • 10.27.1 Xytex Cryo International Company Details
  • 10.27.2 Xytex Cryo International Business Overview
  • 10.27.3 Xytex Cryo International Infertility Services Introduction
  • 10.27.4 Xytex Cryo International Revenue in Infertility Services Business (2015-2020)
  • 10.27.5 Xytex Cryo International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Infertility Services Scope and Market Size
Infertility Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infertility Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Assisted Reproductive Technology (ART)
Infertility drug services
Artificial Insemination
Fertility Surgeries

Market segment by Application, split into
Male
Female

Based on regional and country-level analysis, the Infertility Services market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Infertility Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International